Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Construction in Progress (2019 - 2022)

Clene (CLNN) posted Construction in Progress of $6.7 million for Q3 2022, up 37.39% on a QoQ basis from $4.9 million in Q2 2022, and up 529.97% year-over-year from $1.1 million in Q3 2021.

Analysis

Clene (CLNN) Construction in Progress (2019 - 2022) Analysis & Trends

Clene has reported Construction in Progress for 4 years, with the latest figure at $6.7 million in Q3 2022.

  • On a quarterly basis, Construction in Progress rose 529.97% year-over-year to $6.7 million in Q3 2022; TTM through Sep 2022 was $6.7 million, a 529.97% increase from a year earlier, with the FY2021 full-year figure at $2.1 million, up 318.78% from the prior year.
  • Construction in Progress was $6.7 million for Q3 2022 at Clene, up from $4.9 million in the prior quarter.
  • The five-year high for Construction in Progress was $6.7 million in Q3 2022, with the low at $410000.0 in Q4 2019.
  • Average Construction in Progress over 4 years is $2.2 million, with a median of $1.1 million recorded in 2021.
  • The sharpest annual moves came in 2020 and 2022: Construction in Progress climbed 19.51% in 2020, then soared 529.97% in 2022.
  • Over 4 years, Construction in Progress stood at $410000.0 in 2019, then advanced by 19.51% to $490000.0 in 2020, then soared by 318.78% to $2.1 million in 2021, then jumped by 225.73% to $6.7 million in 2022.
  • The last three Construction in Progress figures came in at $6.7 million (Q3 2022), $4.9 million (Q2 2022), and $3.0 million (Q1 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn -
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Clene 45.69 Mn 45.69 Mn 54,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 6.68 Mn
Jun 30, 2022 4.87 Mn
Mar 31, 2022 2.96 Mn
Dec 31, 2021 2.05 Mn
Sep 30, 2021 1.06 Mn
Jun 30, 2021 821,000.00
Mar 31, 2021 663,000.00
Dec 31, 2020 490,000.00
Dec 31, 2019 410,000.00